Related Experiment Video
Updated: Jan 5, 2026

RNA-seq Analysis of Transcriptomes in Thrombin-treated and Control Human Pulmonary Microvascular Endothelial Cells
Published on: February 13, 2013
Expression of microRNA-514a-5p and its biological function in experimental pulmonary thromboembolism
Yuanyuan Sun1, Xingguo Zhang2, Hua Gao3
1Department of Respiratory Medicine, Shandong Provincial Hospital Affiliated to Shandong University Jinan 250000, Shandong, China.
Abstract:
It is difficult to diagnose pulmonary thromboembolism (PTE) in clinical practice. While microRNAs (miRNAs) have been widely investigated as biomarkers for various diseases, their value as biomarkers for PTE remains largely unknown. In the present study, 83 miRNAs showed altered expression in an intermediate-risk PTE group when compared with their expression in a low-risk PTE group as detected by miRNA microarray analysis. After reviewing those data, hsa-miR-514a-5p was selected as a potential biomarker for PTE progression. Disordered myocardial fibroblast arrangements, broadened intercellular spaces, diapedesis of erythrocytes, and lower numbers of nuclei in the right ventricular wall were observed in rats in a PTE model group when compared to rats in a normal saline (NS) group. Furthermore, hyperexpression of miR-514a-5p exacerbated the morphological characteristics of lung and right ventricular tissues, and caused increased RVHI and lung index values, as well as increased BNP and NT-pro-BNP levels in the PTE model rats, possibly by downregulating Chordin-like 1 (CHRDL1) expression. These results suggest that MiR-514a-5p helps to exasperate PTE development by promoting several aspects of PTE pathology, including inflammation, lung injury, and right ventricular hypertrophy by targeting CHRDL1.
Insights
MicroRNAs (miRNAs) show potential as biomarkers for pulmonary thromboembolism (PTE) progression. Specifically, hsa-miR-514a-5p exacerbates PTE by targeting CHRDL1, worsening lung injury and right ventricular hypertrophy.
Area of Science:
- Biochemistry
- Molecular Biology
- Cardiovascular Research
Background:
- Pulmonary thromboembolism (PTE) diagnosis is challenging.
- MicroRNAs (miRNAs) are emerging biomarkers, but their role in PTE is unclear.
Purpose of the Study:
- To identify potential miRNA biomarkers for PTE progression.
- To investigate the role of hsa-miR-514a-5p in PTE pathogenesis.
Main Methods:
- miRNA microarray analysis to compare intermediate-risk and low-risk PTE groups.
- In vivo rat model of PTE to assess the effects of miR-514a-5p.
- Histological analysis of lung and right ventricular tissues.
- Measurement of right ventricular hypertrophy index (RVHI) and cardiac biomarkers (BNP, NT-pro-BNP).
Main Results:
- 83 miRNAs exhibited altered expression in intermediate-risk PTE.
- hsa-miR-514a-5p was identified as a potential PTE progression biomarker.
- Overexpression of miR-514a-5p in a rat PTE model worsened lung and right ventricular pathology, increased RVHI, and elevated BNP/NT-pro-BNP levels.
- miR-514a-5p possibly exerts its effects by downregulating CHRDL1 expression.
Conclusions:
- hsa-miR-514a-5p exacerbates PTE development by promoting inflammation, lung injury, and right ventricular hypertrophy.
- Targeting CHRDL1 by miR-514a-5p is a potential mechanism driving PTE progression.
- miR-514a-5p warrants further investigation as a therapeutic target and diagnostic biomarker for PTE.
Related Concept Videos
MicroRNAs
MicroRNAs

